chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Multiple events of high fever 104 highest (4 in total); This is a spontaneous report from a non-contactable consumer. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Sep2021 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccines within four weeks prior to the vaccination which included HPV9 (HUMAN PAPILLOMA VACCINE), taken on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 16Sep2021, the patient experienced multiple events of high fever 104 highest (4 in total). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. On 16Sep2021, the patient underwent body temperature test and the result was 104 (unspecified units). Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event multiple events of high fever 104 highest (4 in total) was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain in extremity
Clinical narrative: Horrible headache for 6 days; Nausea; Chills; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an unspecified route of administration in the left arm on 03Aug2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the vaccination. On 04Sep2021, the patient experienced horrible headache for 6 days, nausea, chills and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events horrible headache was resolved on 10Sep2021 while nausea, chills and sore arm was resolved on an unknown date in Sep2021.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Late menstrual cycle.  Should have gotten it around 09/06/21 and it is 2 weeks later and still no menstrual cycle.; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the left arm on 03Sep2021 at 14:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis and COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 06Sep2021, the patient experienced late menstrual cycle. The patient should have gotten it around 06Sep2021 and it was 2 weeks later and still no menstrual cycle. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event late menstrual cycle was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Fatigue, Malaise, Palpitations
Clinical narrative: Dizziness; Pounding heart; Chest pain; Generally feeling ill; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 17Sep2021 at 14:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medication included atenolol (ATENOL) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 18Sep2021, the patient experienced dizziness, pounding heart, chest pain, generally feeling ill and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness, pounding heart, chest pain, generally feeling ill and tiredness was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Pink rash on chest and back; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Sep2021 at 17:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included hepatitis a vaccine (MANUFACTURER UNKNOWN), measles vaccine (MANUFACTURER UNKNOWN), mumps vaccine (MANUFACTURER UNKNOWN), rubella vaccine (MANUFACTURER UNKNOWN), meningococcal vaccine (MANUFACTURER UNKNOWN), varicella zoster vaccine (VARICELLA VACCINE) and bcg vaccine (MANUFACTURER UNKNOWN); all on 13Aug2021 for unknown indications. The patient received other vaccines within four weeks prior to the COVID-19 vaccine. On 11Sep2021, the patient experienced pink rash on chest and back. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included unspecified treatment. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pink rash on chest and back was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Headache, Nausea, Rash
Clinical narrative: Abdominal cramping; Nausea; Vomiting; Generalized rash; Dizziness; Headache; This is a spontaneous report from a non-contactable nurse, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Sep2021 at 16:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included trigeminal neuralgia and ulcerative colitis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included pregabalin (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Sep2021 at 16:30, the patient experienced abdominal cramping, nausea, vomiting, generalized rash, dizziness, headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events abdominal cramping, nausea, vomiting, generalized rash, dizziness, headache was not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Abdominal cramping; Nausea; Vomiting; Generalized rash; Dizziness; Headache; This is a spontaneous report from a non-contactable nurse, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Sep2021 at 16:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included trigeminal neuralgia and ulcerative colitis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included pregabalin (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Sep2021 at 16:30, the patient experienced abdominal cramping, nausea, vomiting, generalized rash, dizziness, headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events abdominal cramping, nausea, vomiting, generalized rash, dizziness, headache was not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain, Dizziness
Clinical narrative: dizziness; ball in the armpit after vaccine; ball in the armpit after vaccine; This is a spontaneous report from a contactable consumer (patient).   A 34-years-old female patient received BNT162B2 (COVID-19 vaccine, Formulation: Solution for injection, Batch/Lot Number: Unknown), dose 1 via an unspecified route of administration in Left Arm on 11Sep2021 at 18:00 (Patient age at vaccination 34 year) as dose 1, single for covid-19 immunisation. The patient medical history includes COVID-19. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE SODIUM) taken 75 ug and received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 12Sep2021 the patient experienced dizziness and ball in the armpit after vaccine. Pfizer have permission to contact the reporter about this event: Yes and Pfizer have permission to contact your/the patient's healthcare provider about this report: No.  Device Date: 22Sep2021. Patient didn't received treatment for dizziness. The outcome of the events was not recovered.    No follow-up attempts are needed. No further information expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic, SARS-CoV-2 test
Clinical narrative: Itchy red rashes all over the body; Itchy red rashes all over the body; Rashes all over the body; This is a spontaneous report from a non-contactable nurse, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in the left arm on 19Sep2021 at 10:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included multivitamins (MANUFACTURER UNKNOWN), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3180) via an unspecified route of administration in the left arm on 29Aug2021 at 10:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 21Sep2021, 2 days after the second dose of vaccine, the patient experienced developed itchy red rashes all over the body. The patient went to an urgent care clinic and was prescribed oral steroids and hydrocortisone (MANUFACTURER UNKNOWN) cream for the rashes. The events had resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 18Sep2021, the patient underwent COVID PCR test (nasal swab) and the result was negative. Therapeutic measures were taken as a result of reported events which included treatment with oral steroids and hydrocortisone (MANUFACTURER UNKNOWN) cream. The clinical outcome of events developed itchy red rashes all over the body was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass, Crying, Headache, Malaise, Pain
Clinical narrative: there is lump under my armpit; my arm feels really it's hurting hard, sort of not bad but it does hurts and I got a lump under it; body ache; headache; feeling kind of yelpy; I'm feeling yucky; This is a spontaneous report from a contactable consumer. This 40-year-old male consumer (patient) reported for himself that: A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection, Lot Number: FF2537 or FF2587, Expiry date: unknown), dose 2 via an unspecified route of administration on 20Sep2021 (at the age of 40-years-old) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection, Lot Number: FC3180), via an unspecified route of administration, on 30Aug2021 (at the age of 40-years-old) as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date in Sep2021 the patient experienced there was lump under my armpit, my arm feels really it's hurting hard, sort of not bad but it does hurts and I got a lump under it, body ache, headache, feeling kind of yelpy and feeling yucky. The patient reported that, he just got vaccine on Monday and in the last couple of days. Patient have been feeling kind of yelpy and then somehow today he got up this morning and his arm feels really It's hurting really hard really sort of not bad but it does hurts and he got a lump under it. So, patient don't know and he called the local pharmacy where got it done and they told him to call Pfizer and report it. Just to like he guess to you guys check on it or see if the side effects or you guys log in you side effects login or whatever. The patient stated that, lot number FF2587 or 37 I don't know. I can hardly read the number here. The patient did not received treatment. The outcome of the events was unknown at the time of reporting.  Follow-up attempts are completed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: there is lump under my armpit; my arm feels really it's hurting hard, sort of not bad but it does hurts and I got a lump under it; body ache; headache; feeling kind of yelpy; I'm feeling yucky; This is a spontaneous report from a contactable consumer. This 40-year-old male consumer (patient) reported for himself that: A 40-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection, Lot Number: FF2537 or FF2587, Expiry date: unknown), dose 2 via an unspecified route of administration on 20Sep2021 (at the age of 40-years-old) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection, Lot Number: FC3180), via an unspecified route of administration, on 30Aug2021 (at the age of 40-years-old) as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date in Sep2021 the patient experienced there was lump under my armpit, my arm feels really it's hurting hard, sort of not bad but it does hurts and I got a lump under it, body ache, headache, feeling kind of yelpy and feeling yucky. The patient reported that, he just got vaccine on Monday and in the last couple of days. Patient have been feeling kind of yelpy and then somehow today he got up this morning and his arm feels really It's hurting really hard really sort of not bad but it does hurts and he got a lump under it. So, patient don't know and he called the local pharmacy where got it done and they told him to call Pfizer and report it. Just to like he guess to you guys check on it or see if the side effects or you guys log in you side effects login or whatever. The patient stated that, lot number FF2587 or 37 I don't know. I can hardly read the number here. The patient did not received treatment. The outcome of the events was unknown at the time of reporting.  Follow-up attempts are completed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Sore injection site became red, itchy and raised one week after injection; Sore injection site became red, itchy and raised one week after injection; Sore injection site became red, itchy and raised one week after injection; Sore injection site became red, itchy and raised one week after injection; Lymph node on same arm became painful one week after; This is a spontaneous report from a non-contactable nurse, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 13Sep2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS) and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and unspecified multivitamin; both taken for unknown indications from an unknown date and unknown if ongoing. On 21Sep2021 at 11:00, the patient had sore injection site became red, itchy and raised one week after injection. Also lymph node on same arm became painful one week after. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore injection site became red, itchy and raised one week after injection and lymph node on same arm became painful one week after was resolving at the time of report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac discomfort, Chest discomfort, Dyspnoea, Heart rate, Pain in extremity
Clinical narrative: Resting tachycardia; Heart pressure continued; 5-10 min after; shortness of breath; 5-10 min after; pressure on right side of chest; Usual sore arm; This is a spontaneous report from a contactable physician, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Sep2021 at 16:45 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. It was unknown if patient had any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Sep2021 at 16:55, 5-10 min after, the patient experienced shortness of breath and pressure on right side of chest. It lessened a few hours after but still felt short of breath. She also experienced usual sore arm that evening and next morning. On 15Sep2021, short breath and heart pressure continued intermittently. On 16Sep2021, third day after vaccine, the patient had put her apple watch on to track her heart that day and specifically during the phases of pressure. The patient had resting tachycardia about 130 beats per minute lasting one to two hours and slowly dropped to about 90 beats per minute average throughout the work day. The patient's usually resting heart rate was about 60 beats per minute. This continued for another few days. The patient had not tracked her heart rate in the last few days to say if the tachycardia had continued or not. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On the 16Sep2021, the patient underwent heart rate test and the result was about 130 beats per minute and 90 beats per minute. On an unknown date, the patient underwent heart rate test and the result was about 60 beats per minute. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 5-10 min after, the patient experienced shortness of breath and pressure on right side of chest, usual sore arm, heart pressure and resting tachycardia were resolving at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Resting tachycardia; Heart pressure continued; 5-10 min after; shortness of breath; 5-10 min after; pressure on right side of chest; Usual sore arm; This is a spontaneous report from a contactable physician, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Sep2021 at 16:45 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. It was unknown if patient had any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Sep2021 at 16:55, 5-10 min after, the patient experienced shortness of breath and pressure on right side of chest. It lessened a few hours after but still felt short of breath. She also experienced usual sore arm that evening and next morning. On 15Sep2021, short breath and heart pressure continued intermittently. On 16Sep2021, third day after vaccine, the patient had put her apple watch on to track her heart that day and specifically during the phases of pressure. The patient had resting tachycardia about 130 beats per minute lasting one to two hours and slowly dropped to about 90 beats per minute average throughout the work day. The patient's usually resting heart rate was about 60 beats per minute. This continued for another few days. The patient had not tracked her heart rate in the last few days to say if the tachycardia had continued or not. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On the 16Sep2021, the patient underwent heart rate test and the result was about 130 beats per minute and 90 beats per minute. On an unknown date, the patient underwent heart rate test and the result was about 60 beats per minute. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 5-10 min after, the patient experienced shortness of breath and pressure on right side of chest, usual sore arm, heart pressure and resting tachycardia were resolving at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Skin discolouration
Clinical narrative: The four fingers on my left hand randomly turn white.; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 14Sep2021 at 08:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Sep2021, the patient experienced the four fingers on her left hand randomly turn white. on an unknown date in Sep2021, the patient underwent COVID-19 test and the result was unknown. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event the four fingers on her left hand randomly turn white was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Musculoskeletal stiffness, Pain
Clinical narrative: Fever of 100.5; Chills; Headache; 24-48 hour symptoms: body aches; Sore/stiffness at injection site; Sore/stiffness at injection site.; 14 day symptoms: blue and yellow bruising at injection site; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on an unknown date in Sep2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications included vitamin d nos (VITAMIN D), cetirizine hydrochloride (ZYRTEC) and ascorbic acid (VITAMIN C), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 10Sep2021, the patient experienced 24 hours symptoms: fever of 100.5 (unspecified units), chills, headache. 24-48 hours symptoms: body aches, sore/stiffness at injection site and 14 days symptoms: blue and yellow bruising at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events 24 hours symptoms: fever of 100.5 (unspecified units), chills, headache was resolved on 11Sep2021, 24-48 hours symptoms: body aches, sore/stiffness at injection site was resolved on an unknown date in Sep2021 and 14 days symptoms: blue and yellow bruising at injection site was resolved on 24Sep2021.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site bruising, Vaccination site pain
Clinical narrative: Fever of 100.5; Chills; Headache; 24-48 hour symptoms: body aches; Sore/stiffness at injection site; Sore/stiffness at injection site.; 14 day symptoms: blue and yellow bruising at injection site; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on an unknown date in Sep2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications included vitamin d nos (VITAMIN D), cetirizine hydrochloride (ZYRTEC) and ascorbic acid (VITAMIN C), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 10Sep2021, the patient experienced 24 hours symptoms: fever of 100.5 (unspecified units), chills, headache. 24-48 hours symptoms: body aches, sore/stiffness at injection site and 14 days symptoms: blue and yellow bruising at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events 24 hours symptoms: fever of 100.5 (unspecified units), chills, headache was resolved on 11Sep2021, 24-48 hours symptoms: body aches, sore/stiffness at injection site was resolved on an unknown date in Sep2021 and 14 days symptoms: blue and yellow bruising at injection site was resolved on 24Sep2021.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Vomiting
Clinical narrative: ''I'' woke up with a terrible, excruciating headache; ''I'' started puking and could not stop.; Started feeling really bad; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in the left arm on 19Sep2021 at 16:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder (PTSD), major depressive disorder, unspecified psychiatric disorder, panic disorder and unspecified personality disorder. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol (VITAMIN D3), citalopram hydrobromide (CELEXA) and valaciclovir (VALACYCLOVIR), all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received codeine (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and experienced drug allergy. On 21Sep2021, Tuesday at 13:00, the patient started feeling really bad and then on the same day at 16:30, the patient started puking and could not stop. The patient could not hold anything down and it made it worse, she finally stopped puking around 22:00. On 23Sep2021, she woke up with a terrible excruciating headache. She took 3 advils and tried to go back to sleep. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event woke up with a terrible, excruciating headache which included treatment with 3 ibuprofens (ADVIL). The clinical outcome of the event started puking and could not stop was resolved on 21Sep2021 at 22:00 whereas the events feeling really bad and woke up with a terrible, excruciating headache was resolving at the time of this report.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Vaginal bleeding starting the day after both vaccines; This is a spontaneous report from a contactable other healthcare professional, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an intramuscular route of administration in the left arm on 31Aug2021 at 14:00 (at the age of 33-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an intramuscular route of administration in the left arm on 21Sep2021 at 15:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On an unknown date in 2021, the day after both vaccines, the patient experienced vaginal bleeding. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vaginal bleeding was resolved on an unknown date in 2021.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Headache, Migraine, Neck pain, Swelling
Clinical narrative: Migraine on right side; Pain goes down into my ear; Pain goes down into my neck; Swelling on that side of face; Swelling on that side of neck; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in the left arm on 13Sep2021 at 14:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified medication for birth control from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Sep2021 at 04:00, the patient experienced migraine on right side, the pain went down into her ear and neck, had swelling on that side of face and neck. She also experienced headache and was still happening for over two weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with some unspecified pain medicine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine on right side, the pain went down into her ear and neck, had swelling on that side of face and neck and headache was not resolved at the time of this report.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Migraine on right side; Pain goes down into my ear; Pain goes down into my neck; Swelling on that side of face; Swelling on that side of neck; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in the left arm on 13Sep2021 at 14:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified medication for birth control from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Sep2021 at 04:00, the patient experienced migraine on right side, the pain went down into her ear and neck, had swelling on that side of face and neck. She also experienced headache and was still happening for over two weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with some unspecified pain medicine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine on right side, the pain went down into her ear and neck, had swelling on that side of face and neck and headache was not resolved at the time of this report.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cardiac disorder, Headache, Migraine
Clinical narrative: Left shoulder pain then shoulder feel like it's going to pop out of place even after 3 weeks of 1st shot/Also left knee feel sore like can't bend it all the way; Migrain turned to headache; Migrain turned to headache; Heart piercing 1st two weeks of 1st shot; This is a spontaneous report received from a contactable consumer (patient). A 42-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), via an unspecified route of administration, administered in Arm Left on 01Sep2021 15:00 (at the age of 42 years old) as dose 1, single for covid-19 immunization at hospital. No relevant medical history reported. There were no concomitant medications. No known allergies. The patient was not pregnant at the time of vaccination. No vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. On 01Sep2021 16:00 the patient experienced Left shoulder pain then shoulder felt like it was going to pop out of place even after 3 weeks of first shot. Also left knee felt sore like could not bend it all the way. Migraine turned to headache. Heart pierced for 1st two weeks of first shot. Therapeutic measures (Tylenol, salves, & massage & tea) were taken as a result of the events. The outcome of the events was not recovered.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.   Follow-up (27Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer, Back pain, Chills, Cough, Migraine
Clinical narrative: Migraine; Nausea; Backache; Cough; Kanker sores in mouth; Fever; Chills; Full body skin rash; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Sep2021 at 17:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 20Sep2021 at 18:15, the patient experienced migraine, nausea, backache, cough, kankersores in mouth, fever, chills and full body skin rash. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measure was taken as a result of rash which included treatment with unspecified cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, nausea, backache, cough, kankersores in mouth, fever, chills and full body skin rash was resolving at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Rash
Clinical narrative: Migraine; Nausea; Backache; Cough; Kanker sores in mouth; Fever; Chills; Full body skin rash; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Sep2021 at 17:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 20Sep2021 at 18:15, the patient experienced migraine, nausea, backache, cough, kankersores in mouth, fever, chills and full body skin rash. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measure was taken as a result of rash which included treatment with unspecified cream. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, nausea, backache, cough, kankersores in mouth, fever, chills and full body skin rash was resolving at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Magnetic resonance imaging, Migraine
Clinical narrative: I have had a headache daily for the last four months, the headache is a migraine; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EIN0168) via an unspecified route of administration on 19May2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on 03Apr2021. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient waited until she felt well and was vaccinated on 19May2021 and was never hospitalized. Since then, she had a headache daily for the last four months from 22May2021. She had been to a neurologist and magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) were clear. The headache was a migraine. The events resulted in doctor or other healthcare professional office/clinic visit. On an unknown date in 2021, the patient underwent MRI and MRA and the result was clear. Therapeutic measures were taken as a result of the event and included treatment with unspecified steroids. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event she had a headache daily for the last four months, the headache was a migraine was not resolved at the time of this report.
Age: 35.0
Sex: U
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: I Started to have tachycardia some months ago and I never had it before; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the right arm on 05May2021 at 14:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 06Apr2021 at 14:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Jun2021 at 14:00, the patient started to have tachycardia some months ago and the patient had never had it before. The event resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event started to have tachycardia some months ago and the patient had never had it before was not resolved at the time of this report.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hordeolum
Clinical narrative: Lingering hip pain; Had styes in eyes; This is a spontaneous report from a contactable consumer. An adult non-pregnant female patient of unknown age received BNT162b2 (COMIRNATY; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, after taking COMIRNATY, the patient had styes in eyes and had lingering hip pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events had styes in eyes and lingering hip pain was resolved with lasting effects on an unknown date at the time of this report.   The batch/lot numbers for BNT162b2 were not provided and will be requested during follow up.